US equities |
MU $953.19 ▼-3.62% NVDA $228.52 ▲+0.97% META $762.50 ▲+2.63% AAPL $341.27 ▲+0.09% MSFT $543.45 ▲+0.43% SNDK $1,482.33 ▼-0.34% AMD $605.53 ▲+1.90% SPCX $156.54 ▼-4.21%
FinancialContent

Latest News about Josh Bartch

Recent news which mentions Josh Bartch

Psychedelic-Based Drugs Biotech Company Begins Trading On UK's AQSE Growth Market
Tickers MYCOF
Tags premium News Josh Bartch
From Benzinga
Two Psychedelic Companies File Patent Applications For Psilocybin And MDMA Analogues, Here's What Could Change
Tickers LOBEF MYCOF
Tags Benzinga Dr/ Rakesh Jetly Markets
From Benzinga
Government-Funded Smoking Cessation Trial Uses Mydecine's New Psilocybin-Derived MYCO-001, Recently FDA-Approved
Tickers MYCOF
Tags News Josh Bartch Market News
From Benzinga